249 related articles for article (PubMed ID: 30244146)
1. Using two-fluid nozzle for spray freeze drying to produce porous powder formulation of naked siRNA for inhalation.
Liang W; Chow MYT; Chow SF; Chan HK; Kwok PCL; Lam JKW
Int J Pharm; 2018 Dec; 552(1-2):67-75. PubMed ID: 30244146
[TBL] [Abstract][Full Text] [Related]
2. Effect of formulation and inhaler parameters on the dispersion of spray freeze dried voriconazole particles.
Liao Q; Lam ICH; Lin HHS; Wan LTL; Lo JCK; Tai W; Kwok PCL; Lam JKW
Int J Pharm; 2020 Jun; 584():119444. PubMed ID: 32445908
[TBL] [Abstract][Full Text] [Related]
3. Inhaled powder formulation of naked siRNA using spray drying technology with l-leucine as dispersion enhancer.
Chow MYT; Qiu Y; Lo FFK; Lin HHS; Chan HK; Kwok PCL; Lam JKW
Int J Pharm; 2017 Sep; 530(1-2):40-52. PubMed ID: 28720537
[TBL] [Abstract][Full Text] [Related]
4. Protein inhalation powders: spray drying vs spray freeze drying.
Maa YF; Nguyen PA; Sweeney T; Shire SJ; Hsu CC
Pharm Res; 1999 Feb; 16(2):249-54. PubMed ID: 10100310
[TBL] [Abstract][Full Text] [Related]
5. Spray freeze drying of small nucleic acids as inhaled powder for pulmonary delivery.
Liang W; Chan AYL; Chow MYT; Lo FFK; Qiu Y; Kwok PCL; Lam JKW
Asian J Pharm Sci; 2018 Mar; 13(2):163-172. PubMed ID: 32104389
[TBL] [Abstract][Full Text] [Related]
6. Development of spray-freeze-dried siRNA/PEI powder for inhalation with high aerosol performance and strong pulmonary gene silencing activity.
Okuda T; Morishita M; Mizutani K; Shibayama A; Okazaki M; Okamoto H
J Control Release; 2018 Jun; 279():99-113. PubMed ID: 29627404
[TBL] [Abstract][Full Text] [Related]
7. Novel Budesonide Particles for Dry Powder Inhalation Prepared Using a Microfluidic Reactor Coupled With Ultrasonic Spray Freeze Drying.
Saboti D; Maver U; Chan HK; Planinšek O
J Pharm Sci; 2017 Jul; 106(7):1881-1888. PubMed ID: 28285981
[TBL] [Abstract][Full Text] [Related]
8. High siRNA loading powder for inhalation prepared by co-spray drying with human serum albumin.
Chow MYT; Qiu Y; Liao Q; Kwok PCL; Chow SF; Chan HK; Lam JKW
Int J Pharm; 2019 Dec; 572():118818. PubMed ID: 31678379
[TBL] [Abstract][Full Text] [Related]
9. Large porous particles for respiratory drug delivery. Glycine-based formulations.
Ogienko AG; Bogdanova EG; Trofimov NA; Myz SA; Ogienko AA; Kolesov BA; Yunoshev AS; Zubikov NV; Manakov AY; Boldyrev VV; Boldyreva EV
Eur J Pharm Sci; 2017 Dec; 110():148-156. PubMed ID: 28479348
[TBL] [Abstract][Full Text] [Related]
10. Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition.
Liao Q; Yip L; Chow MYT; Chow SF; Chan HK; Kwok PCL; Lam JKW
Int J Pharm; 2019 Apr; 560():144-154. PubMed ID: 30731259
[TBL] [Abstract][Full Text] [Related]
11. Constant size, variable density aerosol particles by ultrasonic spray freeze drying.
D'Addio SM; Chan JG; Kwok PC; Prud'homme RK; Chan HK
Int J Pharm; 2012 May; 427(2):185-91. PubMed ID: 22322208
[TBL] [Abstract][Full Text] [Related]
12. Jet-vortex spray freeze drying for the production of inhalable lyophilisate powders.
Wanning S; Süverkrüp R; Lamprecht A
Eur J Pharm Sci; 2017 Jan; 96():1-7. PubMed ID: 27593988
[TBL] [Abstract][Full Text] [Related]
13. Spray-freeze-drying for protein powder preparation: particle characterization and a case study with trypsinogen stability.
Sonner C; Maa YF; Lee G
J Pharm Sci; 2002 Oct; 91(10):2122-39. PubMed ID: 12226840
[TBL] [Abstract][Full Text] [Related]
14. Effect of thermal and shear stresses in the spray drying process on the stability of siRNA dry powders.
Wu J; Wu L; Wan F; Rantanen J; Cun D; Yang M
Int J Pharm; 2019 Jul; 566():32-39. PubMed ID: 31077763
[TBL] [Abstract][Full Text] [Related]
15. Effect of Particle Formation Process on Characteristics and Aerosol Performance of Respirable Protein Powders.
Brunaugh AD; Wu T; Kanapuram SR; Smyth HDC
Mol Pharm; 2019 Oct; 16(10):4165-4180. PubMed ID: 31448924
[TBL] [Abstract][Full Text] [Related]
16. Impact of excipient choice on the aerodynamic performance of inhalable spray-freeze-dried powders.
Wanning S; Süverkrüp R; Lamprecht A
Int J Pharm; 2020 Aug; 586():119564. PubMed ID: 32590097
[TBL] [Abstract][Full Text] [Related]
17. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
[TBL] [Abstract][Full Text] [Related]
18. Formulation and comparison of spray dried non-porous and large porous particles containing meloxicam for pulmonary drug delivery.
Chvatal A; Ambrus R; Party P; Katona G; Jójárt-Laczkovich O; Szabó-Révész P; Fattal E; Tsapis N
Int J Pharm; 2019 Mar; 559():68-75. PubMed ID: 30677482
[TBL] [Abstract][Full Text] [Related]
19. Establishment of an Evaluation Method for Gene Silencing by Serial Pulmonary Administration of siRNA and pDNA Powders: Naked siRNA Inhalation Powder Suppresses Luciferase Gene Expression in the Lung.
Ito T; Okuda T; Takayama R; Okamoto H
J Pharm Sci; 2019 Aug; 108(8):2661-2667. PubMed ID: 30954524
[TBL] [Abstract][Full Text] [Related]
20. Spray freeze drying to produce a stable Delta(9)-tetrahydrocannabinol containing inulin-based solid dispersion powder suitable for inhalation.
van Drooge DJ; Hinrichs WL; Dickhoff BH; Elli MN; Visser MR; Zijlstra GS; Frijlink HW
Eur J Pharm Sci; 2005 Oct; 26(2):231-40. PubMed ID: 16084699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
